Littérature scientifique sur le sujet « Miopatie infiammatorie »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Miopatie infiammatorie ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Miopatie infiammatorie"
Serratrice, J., D. Figarella-Branger, N. Schleinitz, J. F. Pellissier et G. Serratrice. « Miopatie infiammatorie ». EMC - Neurologia 8, no 4 (janvier 2008) : 1–23. http://dx.doi.org/10.1016/s1634-7072(08)70522-1.
Texte intégralAllenbach, Y., et O. Benveniste. « Miopatie infiammatorie ». EMC - Neurologia 20, no 1 (février 2020) : 1–13. http://dx.doi.org/10.1016/s1634-7072(20)43301-x.
Texte intégralThèses sur le sujet "Miopatie infiammatorie"
MARINI, Matteo. « Specific serological profiles in patients with inflammatory myopathies ». Doctoral thesis, 2010. http://hdl.handle.net/11562/343911.
Texte intégralThe research project carried out during the PhD was about the idiopathic inflammatory myopathies. They are classified into three groups: polymyositis, dermatomyositis and inclusion body myositis These acquired diseases have in common the presence of moderate to severe muscle weakness and endomysial inflammation, but each subset retains characteristic clinical, immunopathological, and morphological features. The autoimmune etiology for dermatomyositis and polymyositis is supported by some observations (the presence of circulating autoantibodies, the association with other autoimmune diseases and responsiveness to steroid treatment). The association between malignancy and autoimmune myositis has been largely described and confirmed by numerous epidemiological studies The diagnosis of the malignancy may occur before, concurrently to, or following the diagnosis of myositis but despite this potentially confusing observation, what is quite useful is the knowledge that cancer is usually recognized within 3-5 years of myositis diagnosis, with most diagnoses within 12 months. Is not completely understood if antigens are shared between muscle and tumor cells or if there is a cross-reactivity between some epitopes expressed in both cell types Despite the presence of a humorally-mediated inflammatory response targeting muscle fibers in DM, PM and OS, specific muscle antigens are not yet identified. In the study we characterized the muscle-specific proteins recognized by sera of patients with DM and PM and OS using a 2-DE approach. We also evaluated the sera of patients with myositis and cancer to validate the hypothesis of causal link between the diseases The same techniques were used for the study of other muscle diseases. We identified some muscle proteins specifically recognized by serum of some patients with immune mediated necrotizing myopathy. We found the activation of the complement system and deposition of IgG on the plasma membrane of non necrotic fibers. With proteomic analysis we identified circulating autoantibodies specifically present in the sera of patients with necrotizing myopathy and not in control cases. We then applied this method in proteomics for the study of certain forms of myofibrillar myopathy. This pathologies is characterized by accumulation of proteins (desmin, myotilin, alpha-B crystalline and others) within the muscle fibers. Genetic analysis of proteins present in the deposits showed the presence of mutations. The presence of mutations, however, 'and' have been identified in a small percentage of patients. The etiology of this disease is still unknown. In the study, we identified the presence of inflammatory responses in the muscle and the presence of intracellular accumulation typical of myofibrillar myopathy in two patients. In these patients were excluded mutations in the genes usually involved in this disease. With proteomic study we have identified proteins specifically recognized by sera from these patients and not by control cases. We then identified for the first time a subset of immune-mediated myofibrillar myopathy.
Chapitres de livres sur le sujet "Miopatie infiammatorie"
Campanelli, Caterina, Giuseppe Patuzzo, Elisa Tinazzi et Claudio Lunardi. « Miopatie Infiammatorie ». Dans Le malattie rare del sistema immunitario, 141–47. Milano : Springer Milan, 2013. http://dx.doi.org/10.1007/978-88-470-5394-6_16.
Texte intégralConfalonieri, Paolo. « Miopatie infiammatorie ». Dans Terapia delle malattie neurologiche, 539–46. Milano : Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-1120-5_41.
Texte intégral